MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Kovacs, K; Scheithauer, BW; Lombardero, M; McLendon, RE; Syro, LV; Uribe, H; Ortiz, LD; Penagos, LC

Published Date

  • February 2008

Published In

Volume / Issue

  • 115 / 2

Start / End Page

  • 261 - 262

PubMed ID

  • 17926052

Pubmed Central ID

  • 17926052

Electronic International Standard Serial Number (EISSN)

  • 1432-0533

International Standard Serial Number (ISSN)

  • 0001-6322

Digital Object Identifier (DOI)

  • 10.1007/s00401-007-0279-5

Language

  • eng